38 years of Pulsus

Biotechnology Conferences

Spearheading the Transformation of Medical Research into Knowledge through Scientific Gatherings and Networking

1000+ collaborations across USA, Europe and Asia Pacific

About Biotechnology Conferences

Biotechnology ConferenceBiotechnology Conferences | Plant Biotechnology Conference | Industrial Biotechnology Conference | Animal Biotechnology Conference | Environmental Biotechnology Conference | Medical Biotechnology Conference | Food Biotechnology Conference | Bioinformatics Conference | Nanotechnology Conference | Genetics ConferenceBiotechnology Events | Biotechnology Meetings

We are overwhelmed to welcome all the International Researchers, Speakers and Participants for our upcoming Biotechnology Conference.

Biotechnology is the study of biological systems and creatures in order to create or enhance products for a certain purpose. It is commonly regarded as a strategic technology, crucial to maintaining or regaining worldwide competitiveness, and guaranteed to have a significant economic impact. Biotechnology's main goal is to address human wants and desires in order to improve our quality of life. Biotechnology now comes in a variety of applications and levels of sophistication. They all, however, have the capacity to transform our civilization.

Between 2021 and 2027, the market of biotechnology is expected to develop at a CAGR of about 9.4%, with a market size of over USD 497 billion. Continuous advances in molecular biology have resulted in the emergence of the latest scientific disciplines such as metabolomics, genomics, and proteomics. The creation of therapeutic proteins and other medications has been aided by the growing usage of biotech solutions. The demand for medication research and development has grown as the prevalence of chronic illnesses has increased. Due to the broad nature of the biotechnology application, it is being employed more frequently in various industrial areas. The increasing use of organic goods in agriculture is also contributing to market expansion. By applying creative technologies, growing developments in life sciences are providing several benefits related to healthcare treatments and productivity.

The development of novel techniques and their deployment by businesses has a beneficial influence on the biotech sector and is expected to promote significant market growth. As the world faces critical issues in developing a more sustainable bio-economy, we aim to adopt innovation in Industrial Biotechnology and Bioscience to enable the bio-manufacturing of chemicals and functional goods in a more sustainable manner.

Around 4 out of every 10 drugs are biotech derived, which can be ascribed to the growing demand for orphan drugs and customized treatment. This is causing the influx of emerging and innovative biotechnologies companies, further boosting the market revenue.


Biotechnology Conference | Biotechnology Conferences | Plant Biotechnology Conference | Industrial Biotechnology Conference | Animal Biotechnology Conference | Environmental Biotechnology Conference | Medical Biotechnology Conference | Food Biotechnology Conference | Bioinformatics Conference | Nanotechnology Conference | Genetics Conference | Biotechnology Events | Biotechnology Meetings

Biotechnology is a science-driven industry sector that utilizes molecular biology and living organisms to develop healthcare-related products. Biotechnology companies also produce the processes such as DNA fingerprinting or therapeutics. Biotechnology plays a key role in medicine and pharmaceuticals, but the science is also applied in other areas such as food production, production of biofuels, and genomics.

·         Biotechnology is the division of applied science that utilizes living organisms and their derivatives to develop products and processes.

·         These products and processes feature in medicine, healthcare, environmental safety, and biofuels.

·         Biotech stocks are risky investments since biotech firms frequently spend enormous amounts of money and time producing drugs that might never get to the market.

·         A valuation of a biotech firm should consider the development stage and size of the asset growth.

The emergence of the COVID-19 pandemic is an unusual health concern across the world and has adversely caused the Biotechnology market. An outbreak of SARS-CoV-2 has resulted in a shutdown of vital sections of the global economy, halted the supply of raw materials, interrupted the supply and distribution network, and has put restrictions on the movement of goods, thereby affecting the industry progression.

Despite the pandemic, there has been a substantial improvement in investments in the biotech sector owing to the provision of safety against the SARS-CoV-2 virus. For example, globally growing interest in biotech companies was noticed in 2020 since the onset of the COVID-19 pandemic, with investors investing more than USD 13 billion in Biotechnology companies. It gave opportunities for the pursuit of novel scientific activities, particularly in Biotechnology. Expanding investments in the industry accelerated the development of innovative gene therapies, new drugs, and vaccines in crucial therapeutic areas.

The Biotechnology sector’s growth is moving forward in large and rapid steps since the 1990s. The industry has brought out big companies in the medical space such as Amgen, Gilead Sciences, Celgene, and Biogen Idec. There are some extensive product introductions in biopharma drugs. Here are the most frequently utilized Biotechnology medical products recently introduced including the following:

·         Roche's Rituxan (Used to slow the growth of tumors in several types of cancer).

·         AbbVie's Humira (Used to treat arthritis, Crohn's disease, and psoriasis).

·         Amgen/Pfizer's Enbrel (Used to treat various autoimmune diseases).

Johnson & Johnson ($425 Billion), Roche ($334 Billion), Pfizer ($240 Billion), and Novo Nordisk ($225 Billion) were the top U.S.-based Biotechnology firms in terms of market capitalization.

The Global Biotechnology Market can be divided based on end-user, application, company, and region. The market can be categorized into bio-industrial, bio-pharmaceuticals, bio-agriculture, and Bio-IT based on application. In 2020 with a whole market share of around 34.43%, the bio-pharmaceuticals application is anticipated to influence the market. This can be assigned to the growing prevalence of different infectious and chronic diseases which require novel drugs for treatment. Furthermore, the growing focus on the development of regenerative medicine integrated with increasing pharmaceutical expenditure across the world is further anticipated to carry over the segmental growth.

North America is considered for the biggest share of 44.19% in 2020. The growth of the regional market can be ascribed to various factors such as the extensive R&D activities, the presence of key players, and high healthcare expenditure. In addition, an increasing number of companies operating in the region are receiving drug approvals, which is contributing to the market growth. For instance, in February 2021, Biogen Inc. received the U.S. FDA for PLEGRIDY (peginterferon beta-1a) which is utilized for the treatment of relapsing forms of multiple sclerosis.

The Asia Pacific is expected to enlarge at the fastest growth rate of 16.8% from 2021 to 2028. The growth of the regional market can be mainly ascribed to enhancing supportive government policies, clinical trial services, healthcare infrastructure, and epidemiological factors. In addition, foreign companies are broadly combining with local companies for improving the Biotechnology industry’s growth. For example, in September 2019 for forming Bayer Crop Science Ltd, Bayer AG completed a USD 63 billion merger agreement with Monsanto India. This will aid in incorporating Monsanto's expertise in traits, seeds, and digital farming applications into Bayer’s product portfolio. 

Companies are enlarging their product portfolio through different business development strategies, such as mergers, agreements, and acquisitions. For instance, in September 2020, an Irish Biotechnology firm engaged in the development of inflammasome inhibitors, F. Hoffmann-La Roche Ltd. completed the acquisition of Inflazome. The acquisition will give the company rights to Inflazome’s complete portfolio of the preclinical and clinical small molecules of NLRP3 inhibitors. In addition, the company plans to develop NLRP3 inhibitors for targeting an extensive range of indications. Some significant players in the global Biotechnology market include Abbott, Amgen Inc., AstraZeneca, Biogen, CELGENE CORPORATION, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Lonza, Merck & Co, Novo Nordisk A/S, Novartis AG, Pfizer, Inc., and Sanofi.

The Biotechnology market research includes in-depth details of the industry with forecasts & estimates in terms of revenue in USD from 2016 to 2027, for the below segments:

By Application, 2016 - 2027 (USD Billion)

·         Bioindustries

·         Bioinformatics

·         Biopharmacy

·         Bioservices

·         Bioagriculture

By Technology, 2016 - 2027 (USD Billion)

·         Tissue engineering and regeneration

·         Fermentation

·         NanoBiotechnology

·         DNA sequencing

·         PCR Technology

·         Chromatography

·         Cell-Based Assay

·         Others

The above information is given for the following regions and countries:

·         North America

·         U.S.

·         Europe

·         Canada

·         Germany

·         UK

·         France

·         Italy

·         Asia Pacific

·         Spain

·         Russia

·         Mexico

·         Japan

·         India

·         China

·         South Korea

·         UAE

·         Latin America

·         Brazil

·         Argentina

·         Saudi Arabia

·         South Africa

·         Middle East Asia & Africa

Top Biotechnology Universities in the World:

Biotechnology Conference | Biotechnology Conferences | Plant Biotechnology Conference | Industrial Biotechnology Conference | Animal Biotechnology Conference | Environmental Biotechnology Conference | Medical Biotechnology Conference | Food Biotechnology Conference | Bioinformatics Conference | Nanotechnology Conference | Genetics Conference | Biotechnology Events | Biotechnology Meetings

·         University of Cambridge

·         Stanford University

·         Harvard University

·         Massachusetts Institute of Technology

·         University of Oxford

·         University of California, Berkeley

·         Cornell University

·         University of California, San Diego

·         The University of Queensland, Australia

·         Technical University of Denmark

Here are several organizations that are dedicated to advancing the field of Bioengineering across multiple disciplines. 

Biotechnology Conference | Biotechnology Conferences | Plant Biotechnology Conference | Industrial Biotechnology Conference | Animal Biotechnology Conference | Environmental Biotechnology Conference | Medical Biotechnology Conference | Food Biotechnology Conference | Bioinformatics Conference | Nanotechnology Conference | Genetics Conference | Biotechnology Events | Biotechnology Meetings

·         American Society for Microbiology (ASM)

·         American Association of Pharmaceutical Scientists (AAPS)

·         Biomedical Engineering Society (BMES)

·         Biotechnology Industry Organization (BIO)

.         Institute of Biological Engineering (IBE)

·         Society of Bioprocessing Professionals (SBP)

·         Society for Biomaterials (SFB)

·         Society for Industrial Microbiology (SIM)

.         The International Society for Pharmaceutical Engineering 

Metrics:

Pulsus Group is one of the world’s remarkable Scientific Conference Organizers who have their individuality on all the spectrums of Science, Technology and Business.  A part of every conference series’ success specifically hangs on to how far it reaches the online community. Having an online audience is critical to make an international gathering a great success; be it research or academic or industrial.

Biotechnology is the combination of bioscience and technology. Research personnel, Academicians, Research institutes, Industrialists and students of biotechnology and its related domains are the primary participants who show an overriding interest in attending the biotechnology conferences as represented in the below quoted metrics. Conferences based on bioprocess, microbiology, nanosciences shall come under biotechnology which shows a significantly large number of unique visitors and page views which were proved to be a thriving success.

Pulsus further extends its frontier through maintaining its every conference proceeding in its respective conference webpages and its official social media accounts. Thus, aspiring to have the participation of the international scientific and industrial communities to come and experience the pack of talks, discussions, product exhibitions and alliances. 

Biotechnology Conference
Pulsus Conferences

Biotechnology Conference                                                                                                                                                                                                                Pulsus Conferences

Worldwide Pulsus Biotechnology Events

Other Events